We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

A novel TGFβR2 splice variant in patient with aortic aneurysm and family history for aortic dissection: a case report

    Cecilia Vecoli

    Institute of Clinical Physiology, CNR, Massa, Italy

    Ospedale del Cuore, Fondazione Toscana “G. Monasterio”, Massa, Italy

    ,
    Ilenia Foffa

    *Author for correspondence: Tel.: +39 058 549 3591;

    E-mail Address: ilenia.foffa@cnr.it

    Institute of Clinical Physiology, CNR, Massa, Italy

    Ospedale del Cuore, Fondazione Toscana “G. Monasterio”, Massa, Italy

    ,
    Simona Vittorini

    Ospedale del Cuore, Fondazione Toscana “G. Monasterio”, Massa, Italy

    ,
    Nicoletta Botto

    Ospedale del Cuore, Fondazione Toscana “G. Monasterio”, Massa, Italy

    ,
    Augusto Esposito

    Ospedale del Cuore, Fondazione Toscana “G. Monasterio”, Massa, Italy

    ,
    Sabrina Costa

    Ospedale del Cuore, Fondazione Toscana “G. Monasterio”, Massa, Italy

    ,
    Valeria Piagneri

    Ospedale del Cuore, Fondazione Toscana “G. Monasterio”, Massa, Italy

    ,
    Pierluigi Festa

    Ospedale del Cuore, Fondazione Toscana “G. Monasterio”, Massa, Italy

    &
    Lamia Ait-Ali

    Institute of Clinical Physiology, CNR, Massa, Italy

    Ospedale del Cuore, Fondazione Toscana “G. Monasterio”, Massa, Italy

    Published Online:

    We report the clinical presentation and genetic screening of a 31-year-old man with dilatation of the aortic root and ascending aorta and a positive family history for aortic dissection and sudden death. A novel heterozygous variant in a splice acceptor site (c.1600-1G>T) of TGFβR2 gene was identified by using a targeted multi-gene panel analysis. Bioinformatics tools predicted that the c.1600-1G>T variant is pathogenic by altering acceptor splice site at − 1 position affecting pre-mRNA splicing. These data confirm that the diverging splicing in the TGF-β pathway genes may be an important process in aneurismal disease and emphasize the utility of genetic sequencing in the identification of high-risk patients for a more patient’s management able to improve outcomes and minimize costs for the care of patients with heritable thoracic aortic aneurysm and dissection.

    References

    • 1. Brownstein AJ, Kostiuk V, Ziganshin BA et al. Genes associated with thoracic aortic aneurysm and dissection: 2018 update and clinical implications. Aorta (Stamford) 2018;6:13–20. doi: 10.1055/s-0038-1639612
    • 2. Isselbacher EM, Preventza O, Black JH III et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2022;80:e223–e393. https://doi.org/10.1161/CIR.0000000000001106
    • 3. López-Bigas N, Audit B, Ouzounis C, Parra G, Guigó R. Are splicing mutations the most frequent cause of hereditary disease? FEBS Lett. 2005;579:1900–1903. doi: 10.1016/j.febslet.2005.02.047
    • 4. Mizuguchi T, Collod-Beroud G, Akiyama T et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat. Genet. 2004;36:855–860. doi: 10.1038/ng1392
    • 5. Kurtovic S, Paloschi V, Folkersen L, Gottfries J, Franco-Cereceda A, Eriksson P. Diverging alternative splicing fingerprints in the transforming growth factor-β signaling pathway identified in thoracic aortic aneurysms. Mol. Med. 2011;17:665–675. doi: 10.2119/molmed.2011.00018
    • 6. De Cario R, Sticchi E, Lucarini L et al. Role of TGFBR1 and TGFBR2 genetic variants in Marfan syndrome. J. Vasc. Surg. 2018;68:225–233.e5. doi: 10.1016/j.jvs.2017.04.071
    • 7. Panesi P, Foffa I, Sabina S, Ait Ali L, Andreassi MG. Novel TGFBR2 and known missense SMAD3 mutations: two case reports of thoracic aortic aneurysms. Ann. Thorac. Surg. 2015;99:303–305. doi: 10.1016/j.athoracsur.2014.02.068
    • 8. Stheneur C, Collod-Béroud G, Faivre L et al. Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys–Dietz syndrome and related disorders. Hum. Mutat. 2008;29:e284–e295. doi: 10.1002/humu.20871
    • 9. Singh KK, Rommel K, Mishra A et al. TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys–Dietz syndrome. Hum. Mutat. 2006;27:770–777. doi: 10.1002/humu.20354
    • 10. Pannu H, Fadulu V, Chang J et al. Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 2005;112:513–520.
    • 11. Tran-Fadulu V, Pannu H, Kim DH et al. Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J. Med. Genet. 2009;46:607–613. doi: 10.1136/jmg.2008.062844
    • 12. Jondeau G, Ropers J, Regalado E et al. International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations: results of the MAC (Montalcino Aortic Consortium). Circ. Cardiovasc. Genet. 2016;9:548–558. doi: 10.1161/CIRCGENETICS.116.001485
    • 13. Seike Y, Matsuda H, Ishibashi-Ueda H et al. Surgical outcome and histological differences between individuals with TGFBR1 and TGFBR2 mutations in Loeys–Dietz syndrome. Ann. Thorac. Cardiovasc. Surg. 2021;27:56–63. doi: 10.5761/atcs.oa.20-00223